Banco Bilbao Vizcaya Argentaria’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
VPM
VCM
S
Banco Bilbao Vizcaya Argentaria's NVAX Position: Q1 2026 in Review
Banco Bilbao Vizcaya Argentaria reduced its Novavax (NVAX) stake by 47% in Q1 2026, selling an estimated $86.3K and leaving 10,531 shares worth $82.8K. The position accounts for ﹤0.01% of the portfolio, ranked #722.
Banco Bilbao Vizcaya Argentaria first reported a position in NVAX in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.9M in Q1 2022. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Banco Bilbao Vizcaya Argentaria held 10,531 shares of Novavax worth $82.8K as of Q1 2026.
- Banco Bilbao Vizcaya Argentaria sold 9,516 Novavax shares in Q1 2026, an estimated $86.3K.
- Novavax made up ﹤0.01% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #722 holding.
- Banco Bilbao Vizcaya Argentaria first reported a position in Novavax in Q2 2021 and has held it in 20 quarters since.
- Banco Bilbao Vizcaya Argentaria's Novavax position peaked at $3.9M in Q1 2022.
- 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.